Cargando…

Maribavir for Cytomegalovirus Treatment in the Real World—Not a Silver Bullet

Detalles Bibliográficos
Autores principales:	Fung, Monica, DeVoe, Catherine, Spottiswoode, Natasha, Doernberg, Sarah B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830537/ https://www.ncbi.nlm.nih.gov/pubmed/36632422 http://dx.doi.org/10.1093/ofid/ofac686

Ejemplares similares

Evaluating the Safety of Maribavir for the Treatment of Cytomegalovirus
por: Gandhi, Ronak G, et al.
Publicado: (2022)

The effects of maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein
por: Shannon-Lowe, Claire D, et al.
Publicado: (2010)

Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient
por: Schubert, Axel, et al.
Publicado: (2013)

Drug Resistance Mutations and Associated Phenotypes Detected in Clinical Trials of Maribavir for Treatment of Cytomegalovirus Infection
por: Chou, Sunwen, et al.
Publicado: (2020)

415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis
por: DeVoe, Catherine, et al.
Publicado: (2018)

Detection of Low Frequency Multi-Drug Resistance and Novel Putative Maribavir Resistance in Immunocompromised Pediatric Patients with Cytomegalovirus
por: Houldcroft, Charlotte J., et al.
Publicado: (2016)

Population pharmacokinetic modeling and simulation of maribavir to support dose selection and regulatory approval in adolescents with posttransplant refractory cytomegalovirus
por: Sun, Kefeng, et al.
Publicado: (2023)

Health literacy: setting an international collaborative research agenda
por: Protheroe, Joanne, et al.
Publicado: (2009)

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial( )
por: Avery, Robin K, et al.
Publicado: (2021)

Placental transfer of Letermovir & Maribavir in the ex vivo human cotyledon perfusion model. New perspectives for in utero treatment of congenital cytomegalovirus infection
por: Faure Bardon, Valentine, et al.
Publicado: (2020)

Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir
por: Gill, Rachel B, et al.
Publicado: (2009)

Is Silver the Ultimate Antimicrobial Bullet?
por: Turner, Raymond J
Publicado: (2018)

Synthesis of New Imidazopyridine Nucleoside Derivatives Designed as Maribavir Analogues
por: Papadakis, Georgios, et al.
Publicado: (2020)

2685. Oral Third-Generation Cephalosporins vs. Levofloxacin for Antibacterial Prophylaxis in Neutropenic Patients with Hematologic Malignancies
por: DeVoe, Catherine, et al.
Publicado: (2019)

Correction to: Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Publicado: (2023)

Pre-referral rectal artesunate is no “magic bullet” in weak health systems
por: Hetzel, Manuel W., et al.
Publicado: (2023)

Heparin: The Silver Bullet of Aneurysmal Subarachnoid Hemorrhage?
por: Khattar, Nicolas K., et al.
Publicado: (2018)

ABX464: a good drug candidate instead of a magic bullet
por: Berkhout, Ben, et al.
Publicado: (2015)

Identifying “Real” Patients in the Real World
por: Callahan, Sean J.
Publicado: (2020)

Effects of Maribavir on P‐Glycoprotein and CYP2D6 in Healthy Volunteers
por: Song, Ivy H., et al.
Publicado: (2019)

21. Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results
por: Pereira, Marcus, et al.
Publicado: (2021)

Maribavir for Refractory or Resistant Cytomegalovirus Infections in Hematopoietic-cell or Solid-organ Transplant Recipients: A Randomized, Dose-ranging, Double-blind, Phase 2 Study
por: Papanicolaou, Genovefa A, et al.
Publicado: (2019)

Could Protons and Carbon Ions Be the Silver Bullets Against Pancreatic Cancer?
por: Huart, Camille, et al.
Publicado: (2020)

How to run successful projects II: the silver bullet
por: O'Connell, Fergus
Publicado: (1994)

How to run successful project III: the silver bullet
por: O'Connell, Fergus, et al.
Publicado: (2001)

Polishing the tarnished silver bullet: the quest for new antibiotics
por: Blaskovich, Mark A.T., et al.
Publicado: (2017)

Diet-derived microRNAs: unicorn or silver bullet?
por: Witwer, Kenneth W., et al.
Publicado: (2017)

Radiation Biomarkers: Silver Bullet, or Wild Goose Chase?
por: Rutten, Eric Andreas, et al.
Publicado: (2021)

No silver bullet: interpretable ML models must be explained
por: Marques-Silva, Joao, et al.
Publicado: (2023)

Real world and hyper reality
por: Gautret, Philippe, et al.
Publicado: (2021)

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
por: Suryawanshi, Rahul, et al.
Publicado: (2022)

Reply to Callahan: Identifying “Real” Patients in the Real World
por: Dempsey, Timothy M.
Publicado: (2020)

Evaluation of the Effect of Maribavir on Cardiac Repolarization in Healthy Participants: Thorough QT/QTc Study
por: Ilic, Katarina, et al.
Publicado: (2020)

S294: MARIBAVIR (MBV) VERSUS INVESTIGATOR-ASSIGNED THERAPY FOR REFRACTORY CYTOMEGALOVIRUS (CMV) INFECTION: SUBGROUPS ANALYSES OF PHASE 3 STUDY BY RESISTANCE STATUS KNOWLEDGE REPORTED BY INVESTIGATORS.
por: Duarte, Rafael F, et al.
Publicado: (2023)

Aripiprazole in the treatment of acute episode of schizophrenia: a real-world study in China
por: Li, Qian, et al.
Publicado: (2023)

Ontologies: a silver bullet for knowledge management and electronic commerce
por: Fensel, Dieter
Publicado: (2001)

Systemic Capillary Leak Syndrome: Is Methylene Blue the Silver Bullet?
por: Umbrello, Michele, et al.
Publicado: (2014)

Arginine methylation: the promise of a ‘silver bullet’ for brain tumours?
por: Samuel, Sabrina F., et al.
Publicado: (2021)

No silver bullet? Snow leopard prey selection in Mt. Kangchenjunga, Nepal
por: Thapa, Kamal, et al.
Publicado: (2021)

Objective-C
por: DeVoe, Jiva
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ss64g6s9luibojh41sqe0jl03s